Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crystal Formulation Services is a China-based oral formulation development and manufacturing company focused on innovative small molecule drug products. Founded in 2021 in Suzhou Industrial Park, it operates as a wholly owned subsidiary of Crystal Pharmatech and provides formulation CDMO services spanning preformulation, analytical R&D, clinical supply, GMP manufacturing, packaging, labeling, storage, and distribution. The company emphasizes oral solid dosage development, including enabling formulations for poorly water-soluble compounds, mini-tablet pediatric dosage forms, spray drying, and hot-melt extrusion. Its facilities and quality systems are presented as aligned with NMPA, FDA, and EMA expectations, and the business supports projects from preclinical development through commercial manufacturing. Overall, CFS appears to be a service provider rather than a therapeutics pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crystal Formulation Services.